It is the thesis of this paper that most therapeutic trials are inadequately formulated, and this from the earliest stages of their conception. Their inadequacy is basic, in that the trials may be aimed at the solution of one or other of two radically different kinds of problem; the resulting ambiguity affects the definition of the treatments, the assessment of the results, the choice of subjects and the way in which the treatments are compared. It often occurs that one type of approach is ethically less defensible than the other, or may even be ruled out altogether on ethical grounds. We postpone consideration of this aspect of the question until a later section.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jclinepi.2009.01.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The characteristic of poverty-alleviation behavioral strategies of the rural poor population and their relationship with socio-demographic factors.
Front Psychol
December 2024
School of Psychology, Shaanxi Normal University, Xi'an, Shaanxi, China.
Objective: The primary objective of this study is to investigate the fundamental patterns and characteristics of poverty-alleviation behavior strategies among rural poor population. It aims to examine the association between the key socio-demographic characteristics of these populations and their poverty-alleviation strategies, thereby identifying the individual and sociocultural factors related to these behaviors.
Methods: This study employs a questionnaire designed to assess poverty-alleviation behavior strategies among rural poor population.
How pragmatic are randomised controlled trials evaluating minimally invasive surgery for oesophageal cancer? A methodological review of trial design using the Pragmatic-Explanatory Continuum Indicator Summary-2 (PRECIS-2) tool.
BMJ Open
December 2024
Centre for Surgical Research, University of Bristol, Bristol, UK.
Article Synopsis
- The study evaluates the validity and applicability of RCTs comparing minimally invasive and open surgeries for oesophageal cancer from January 2012 to June 2023.
- Only nine RCTs were found, with just one deemed pragmatic due to narrow eligibility criteria and single-centre designs limiting the generalizability of results.
- Recommendations include developing clearer guidelines for defining pragmatic trials to potentially enhance the applicability of future surgical RCTs in clinical practice.
PRECIS-2 used as an implementation science tool for global environmental health: A cross-sectional evaluation of the Ecolectivos study protocol to reduce burning of household plastic waste in rural Guatemala.
PLoS One
January 2025
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States of America.
Background: Randomized controlled trials (RCTs) that evaluate the efficacy of an intervention remain underutilized in community-based environmental health research. RCTs that use a pragmatic design emphasize the effectiveness of interventions in complex, real world settings. Pragmatic trials may be especially relevant when community-based interventions address social and environmental determinants that threaten health equity.
View Article and Find Full Text PDFEvaluating the performance of personality-based profiling in predicting physical activity.
BMC Psychol
December 2024
Human Informatics and Interaction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, 305-8566, Japan.
Background: Profiling or clustering individuals based on personality and other characteristics is a common statistical approach used in marketing, medicine, and social sciences. This approach improves data simplicity, supports the implementation of a data-driven decision-making process, and guides intervention strategies, such as personalized care. However, the clustering process involves loss of information owing to the discretization of continuous variables.
View Article and Find Full Text PDFAdvice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and Disallowing Studies Where Bioavailability Is Not Proven.
Pharmaceuticals (Basel)
October 2024
College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.
Randomized controlled trials (RCTs) are the gold standard for testing the safety and efficacy of new drugs and biologicals. The US Food and Drug Administration (FDA) has proactively improved the trial designs to make them scientifically rational while avoiding unnecessary human exposure. Several new guidelines by the FDA have come in 2024 that address consolidating the RCTs with the Real-World Evidence (RWE) trials, decentralizing the testing platforms, and allowing the point-of-use clinicians to participate.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!